InControl web platform enters pilot testing for older adults with chronic musculoskeletal pain
Chronic musculoskeletal pain remains one of the most persistent causes of disability in later life, and it often erodes mobility, activity levels, and quality of life long before any procedure or medication can restore day-to-day function. The InControl pilot study is designed to test whether a structured web-based intervention can be delivered in a way that older adults will actually use, tolerate, and complete. Its focus is not on proving efficacy yet, but on determining whether the research plan itself can survive first contact with routine clinical reality.
The platform pairs exercise content with pain science education, a combination that fits the biology of chronic pain in older adults. Exercise can support movement confidence, preserve physical function, and reduce deconditioning, while education may help reframe pain beliefs and improve self-management. In digital care, those two elements matter because chronic pain is rarely driven by a single mechanism; sensory, psychological, and functional factors typically interact, and web-based tools only work if they address more than one of them.
The study is registered to recruit 34 participants aged 60 years or older with chronic musculoskeletal pain at the Local Health Unit of Aveiro Region. It uses a randomized, parallel-group, mixed-methods design with two arms: usual care and the InControl intervention. The intervention period lasts eight weeks and combines in-person sessions with remote components, a structure intended to bridge digital convenience with enough guided contact to support uptake in an older cohort that may vary widely in comfort with technology.
Feasibility endpoints will decide whether the trial architecture is workable
Recruitment, retention, adherence, refusal, and dropout rates sit at the center of this pilot because digital pain interventions often fail at the level of participation before they fail at the level of physiology. If older adults do not enroll, stay engaged, and complete the program, even a well-designed therapeutic concept cannot be tested properly in a later randomized trial. Feasibility metrics will therefore determine whether the protocol can support a larger study without substantial redesign.
A single sentence captures the study’s practical importance: if adherence is poor, the platform cannot be judged fairly as a treatment.
The use of a pilot framework is especially appropriate here because the research question is methodologic as much as clinical. Investigators need to know whether the recruitment pathway is realistic, whether the intervention sequence is manageable, and whether the balance between in-person and remote support is sufficient for older adults living with chronic pain. Those details shape trial integrity, but they also shape eventual implementation in primary care or community-based rehabilitation settings.
Usability and acceptability will be measured alongside patient-reported outcomes
Usability will be evaluated with the System Usability Scale, a standard approach for assessing how intuitive and workable a digital interface feels to end users. Acceptability and appropriateness will be measured through a questionnaire and semi-structured interviews, which should provide a clearer picture of what participants find helpful, confusing, burdensome, or motivating. In older adults with chronic pain, those impressions are not peripheral; they often determine whether an intervention becomes a daily habit or another abandoned health app.
The qualitative component adds needed clinical texture. Interviews can reveal whether participants understand the exercise instructions, whether the pain education content feels credible, and whether the blend of online and face-to-face contact fits their routines and limitations. A platform may perform well on paper and still fail at bedside-level practicality if the interface is hard to navigate or if the intervention rhythm does not match the pace of life with persistent pain.
Secondary outcomes will probe whether the platform reaches beyond convenience
Pain, physical function, psychological factors, quality of life, and cognitive function are listed as secondary outcomes. Those domains matter because chronic musculoskeletal pain rarely exists in isolation; it can shape mood, confidence with movement, participation in social roles, and perceived cognitive effort. Even in a small pilot, tracking these measures can help determine whether the intervention is touching the pathways most likely to matter in a future efficacy trial.
The study design does not promise a definitive answer on symptom improvement, and it should not. Its role is to establish whether the intervention can be delivered consistently enough to justify a larger, more definitive randomized controlled trial. If the platform proves usable and the study procedures prove workable, the next phase can focus on whether the combination of exercise and pain education improves outcomes beyond usual care.
This is where digital rehabilitation can either earn a place in practice or stall after a promising concept.
Why this protocol matters for digital pain care in later life
Older adults often face a convergence of barriers that make traditional pain management difficult: travel burden, limited access to specialized services, mobility constraints, and the cumulative effects of chronic symptoms. A web-based intervention can reduce some of those barriers, but only if the design respects the realities of aging, multimorbidity, and varying digital literacy. The InControl protocol reflects that challenge by embedding both remote delivery and face-to-face contact rather than assuming that fully virtual care is automatically sufficient.
The research question is clinically relevant because musculoskeletal pain in later life is common, disabling, and difficult to manage with a single strategy. Exercise and education each have a plausible mechanistic role, yet adherence is often the limiting step. A platform that is acceptable, understandable, and feasible could become a practical route to support self-management for people who are otherwise underserved by conventional services.
Trial registration anchors the protocol in a formal development pathway
The study is registered at ClinicalTrials.gov under NCT07774416, with registration dated August 18, 2026. That registration gives the protocol a transparent framework before recruitment and data collection advance, which is especially important for pilot work intended to inform a future large-scale randomized controlled trial. For now, the central question is straightforward: can this web-based model be delivered well enough to justify testing it as a treatment strategy for older adults living with chronic musculoskeletal pain?
The answer will depend less on a dramatic clinical endpoint than on the cumulative weight of usability, adherence, retention, and participant experience. Those are the measures that will decide whether the next trial can move forward on solid methodological ground.